Entity
  • PK MED

    Created in 2019
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    687
  • Activities

  • Technologies

  • Entity types

  • Location

    14 Rue Jean Antoine de Baïf, 75013 Paris, France

    Paris

    France

  • Employees

    Scale: 2-10

    Estimated: 10

  • Engaged corporates

    5
    1 4
  • Added in Motherbase

    4 months, 3 weeks ago
Description
  • Value proposition

    Tailor-designed drug implants ​for local treatments.
    Founded by Truffle Capital.

    PK MED is a French innovative biotech company, privately owned and established in 2019 with the support of Truffle Capital, a European Venture Capital firm specializing in Life sciences. PK MED was created around a small team of passionate and experienced experts in pharmaceutical and medical sciences, drug delivery and biomaterials design.

    PK MED specializes in the innovative development of custom-designed, injectable, and biodegradable micro-implants. Our expertise spans across critical healthcare domains, focusing on drug delivery systems for rheumatology and enhancing cell-homing techniques to improve bone marrow transplantation outcomes.

    The company has developed a portfolio of early projects in indications with high unmet medical needs, starting with Gout flare, Osteoarthritis and Hemoglobinopathies.

    Drug Delivery, Drug reformulation, Drug repurposing, Biomaterials, Pharmaceuticals, Biotechnology, BioTech, and Innovation

  • Original language

    Tailor-designed drug implants ​for local treatments.
    Founded by Truffle Capital.

    PK MED is a French innovative biotech company, privately owned and established in 2019 with the support of Truffle Capital, a European Venture Capital firm specializing in Life sciences. PK MED was created around a small team of passionate and experienced experts in pharmaceutical and medical sciences, drug delivery and biomaterials design.

    PK MED specializes in the innovative development of custom-designed, injectable, and biodegradable micro-implants. Our expertise spans across critical healthcare domains, focusing on drug delivery systems for rheumatology and enhancing cell-homing techniques to improve bone marrow transplantation outcomes.

    The company has developed a portfolio of early projects in indications with high unmet medical needs, starting with Gout flare, Osteoarthritis and Hemoglobinopathies.

  • PK MED | Treatment in gout flares

    PK MED has developed a portfolio of early projects in indications with high unmet medical needs, starting with Gout flare (PKM-01), Osteoarthritis (PKM-011) and Hemoglobinopathies (PKM-02).

  • https://www.pk-med.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Auvergne-Rhone-Alpes Entreprises - Isère
Auvergne-Rhone-Alpes Entreprises - Isère
National and local authorities, Business Consulting and Services
Auvergne-Rhone-Alpes Entreprises - Isère
National and local authorities, Business Consulting and Services
Other

27 Sep 2024


Leem
Leem
Startup accelerator & VC, Pharmaceutical Manufacturing
Leem
Startup accelerator & VC, Pharmaceutical Manufacturing
Other

31 Jan 2024


France Biotech
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research
Other

31 Jan 2024


Lyonbiopôle Auvergne-Rhône-Alpes
Lyonbiopôle Auvergne-Rhône-Alpes
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Lyonbiopôle Auvergne-Rhône-Alpes
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Other

16 Nov 2024


Bpifrance
Bpifrance
Bank, Banking
Bpifrance
Bank, Banking
Other

23 Jul 2024


Similar entities
Loading...
Loading...
Social network dynamics